Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Surmodics, Inc.

Surmodics is involved in medical device coatings and in vitro diagnostics. It provides customized coatings for medical devices and chemical components for in vitro diagnostic tests.

Metric
Company Name	Surmodics, Inc.
Symbol	SRDX
MSH ID	COM:SURMODICS
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	US
Stage
Employee Count	376
Website	surmodics.com
LinkedIn
Founders

Metric
Market Cap	600.57M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	126.08M
Revenue (LTM)
Revenue (NTM)
Gross Profit	93.05M
EBITDA	-5.64M
Operating Income	-5.64M
Net Income	-11.54M
EPS	-0.82
Diluted EPS	-0.82
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.58
Operating Profit Margin	0.13
EBITDA Margin	-0.04
Net Profit Margin	0.09
Return on Equity	0.11
Return on Assets	0.07
Return on Capital Employed	0.12

COM:SURMODICS

Surmodics

Last Close

39.19

22/11 21:00

Market Cap

600.57M

Beta: -

Volume Today

174.41K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	79.33
P/B Ratio	3.59
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.89
EV Multiple	471.14

Metric
Days Sales Outstanding	34.12
Days Payables Outstanding	15.19
Days Inventory Outstanding	111.06
Operating Cycle	181.87
Cash Conversion Cycle	159.28
Asset Turnover	0.78

Metric
Operating Cash Flow	248K
Free Cash Flow	-3.24M
Cash Flow to Debt	1.20
Operating Cash Flow/Sales	0.18
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	36.12M
Accounts Receivable	-5.24M
Inventory	15.17M
Goodwill	44.64M
Debt to Capitalization	0.22
Debt to Assets	0.16
Current Ratio	4.84
Quick Ratio	3.75

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.06
R&D to Revenue	0.07
SG&A to Revenue	0.19